Venous thromboembolic and bleeding risk in population with obesity hospitalized for an acute medical illness receiving enoxaparin for thromboprophylaxis
Walter Ageno, Juan I Arcelus, Christine Stroh, Yasmina Djoudi, Mohamed Abdel-Moneim, Irfan Khan, Ekaterina Ponomareva, Marc Carrier · 2026
Read Venous thromboembolic and bleeding risk in population with obesity hospitalized for an acute medical illness receiving enoxaparin for thromboprophylaxis by Walter Ageno, Juan I Arcelus, Christine Stroh, Yasmina Djoudi, Mohamed Abdel-Moneim, Irfan Khan, Ekaterina Ponomareva, Marc Carrier (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13272523.txt.
Description
Walter Ageno and co-authors examine, in a 2026 study, the risks of blood clots and major bleeding in hospital patients with obesity who receive a preventive blood thinner. People with obesity admitted with an acute illness face a higher clot risk. Yet doctors have little guidance on who most needs protection, or who might bleed. The team drew on a large United States health database to study patients given enoxaparin.
More than fifty-eight thousand patients qualified, and about three in ten had the most severe level of obesity. Just over half received a higher dose of the drug, while the rest got the standard dose. Over ninety days of follow-up, clots were uncommon but real, and bleeding was rarer still. Cancer admissions carried the highest clot rates. A past clot or past bleed proved the strongest warning sign for the same event recurring.
Catalog record
| CREATOR | Walter Ageno, Juan I Arcelus, Christine Stroh, Yasmina Djoudi, Mohamed Abdel-Moneim, Irfan Khan, Ekaterina Ponomareva, Marc Carrier |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |